Form 4: Callan JMB Inc. Executive David J. Croyle Increases Stake in Company
SEC Form 4 Filing
David J. Croyle, Chief Medical Officer and 10% owner of Callan JMB Inc., reports acquiring additional shares of common stock.
Summary
- On February 5, 2025, David J. Croyle acquired 24,375 shares of Callan JMB Inc. common stock at a price of $4 per share.
- This transaction increased his indirect beneficial ownership through Warehouse Asset Management, LLC, in which he holds a 39% ownership interest.
- Following the transaction, Mr. Croyle directly owns 750,000 shares and indirectly owns 24,375 shares through Warehouse Asset Management, LLC.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition by an insider. The purchase itself is a positive sign, but the filing is simply a regulatory requirement.
Positives
- An executive's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders.
Stakeholder Impact
- The stock purchase by a key executive could positively influence investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 02/05/2025 | Date of transaction: Acquisition of common stock. |
| 03/14/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.